First-half pharmaceutical sales driven by leading products

Despite protracted business slump, the domestic major pharmaceutical firms saw more than 10 percent growth in the first six-month sales revenue, fueled by brisk sales of their flagship products.

Market experts said the trend has been mainly attributed to reinforced marketing activities of major pharmaceutical firms in an attempt to lure customers back to their renowned brands and jump-start ...